Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- HORIZON IIIndependent statistical analysis of Cediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- HORIZON-HCMIndependent statistical analysis of A Study of Mavacamten in Obstructive Hypertrophic Cardiomyopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05414175).
- HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005: Complete Statistical AnalysisIndependent statistical analysis of HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Hormonal Contraception and Vaginal Health: Complete Statistical AnalysisIndependent statistical analysis of Hormonal Contraception and Vaginal Health: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00612508).
- Hormonal Factors in the Treatment of Anorexia Nervosa: Complete Statistical AnalysisIndependent statistical analysis of Hormonal Factors in the Treatment of Anorexia Nervosa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01121211).
- Hormone Replacement and Neural Cardiovascular Control in Postmenopausal Women: Complete Statistical AnalysisIndependent statistical analysis of Hormone Replacement and Neural Cardiovascular Control in Postmenopausal Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01633814).
- Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Hospital to Home Outcomes: Complete Statistical AnalysisIndependent statistical analysis of Hospital to Home Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02081846).
- Hospital Waterbirth Trial to Measure Maternal and Neonatal Outcomes: Complete Statistical AnalysisIndependent statistical analysis of Hospital Waterbirth Trial to Measure Maternal and Neonatal Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05175599).
- Hospital-based Patient Navigation and Smoking Cessation: Complete Statistical AnalysisIndependent statistical analysis of Hospital-based Patient Navigation and Smoking Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03452371).
- Host Modulatory Effects of β-glucan on Localized Aggressive Periodontitis: Complete Statistical AnalysisIndependent statistical analysis of Host Modulatory Effects of β-glucan on Localized Aggressive Periodontitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02402296).
- HOTIndependent statistical analysis of Autologous Stem Cell and Hyperbaric Oxygen Therapy in Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- HOTIndependent statistical analysis of One-step HCV RNA Testing Among SSP Participants (HOT Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06634342).
- HOTFUNIndependent statistical analysis of Heat Shock Therapy to Improve Mitochondrial Function in Neuropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05070741).
- How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis: Complete Statistical AnalysisIndependent statistical analysis of How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- HPA axisIndependent statistical analysis of DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis: primary endpoint results, effect estimate with confidence…
- HPCRTIndependent statistical analysis of Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- HPVIndependent statistical analysis of An Intervention Study To Improve Human PapillomaVirus ( HPV) Immunization in Haitian and African American Girls: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- HPVIndependent statistical analysis of Immunogenicity to Human Papillomavirus Vaccine (Gardasil) Among IBD Patients on Immunosuppressive Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- HPV Vaccine Intervention for Young Sexual Minority Men: Complete Statistical AnalysisIndependent statistical analysis of HPV Vaccine Intervention for Young Sexual Minority Men: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04032106).
- HREIndependent statistical analysis of Protonics Knee Brace Versus Hamstring Resisted Exercise (HRE) on Individuals With Patellofemoral Pain Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- HRSA NutritionIndependent statistical analysis of Nutritional Status and Enteral Absorption Capability After Brain Death: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00858390).
- HRVIndependent statistical analysis of Heart Rate Variability in Trauma Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00795535).
- HRVB-SCTIndependent statistical analysis of Heart Rate Variability Biofeedback for Smoking Cessation Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05224050).
- HSCT for High Risk Inherited Inborn Errors: Complete Statistical AnalysisIndependent statistical analysis of HSCT for High Risk Inherited Inborn Errors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00383448).
- HSDDIndependent statistical analysis of 2. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- HSG and Tubal Patency Study: Complete Statistical AnalysisIndependent statistical analysis of HSG and Tubal Patency Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02146248).
- HSIIndependent statistical analysis of Home Safety Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06216327).
- HSPvsHSPASIIndependent statistical analysis of Hot Snare Versus Hot Snare Polypectomy With Saline Injection for Colorectal Polyps: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- HSV1/HCVIndependent statistical analysis of Herpes Simplex Type 1 Suppression in Hepatitis C: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01580995).
- HUCSIndependent statistical analysis of Human Use Condition Study- Evaluation of Implanted Leads in Humans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04320849).
- HULKIndependent statistical analysis of Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- HUM15709Independent statistical analysis of Using FDG-PET During Radiation Therapy in Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01190527).
- HUM21469Independent statistical analysis of Palonosetron for the Treatment of Nausea and Vomiting in Terminally Ill Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Human Amniotic Membrane to Decrease Post Operative Atrial Fibrillation: Complete Statistical AnalysisIndependent statistical analysis of Human Amniotic Membrane to Decrease Post Operative Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04130061).
- Human Amniotic Tissue-derived Allograft, NuCel, in Posteriolateral Lumbar Fusions for Degenerative Disc Disease: Complete Statistical AnalysisIndependent statistical analysis of Human Amniotic Tissue-derived Allograft, NuCel, in Posteriolateral Lumbar Fusions for Degenerative Disc Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Human Challenge Model Refinement With Enterotoxigenic Escherichia Coli Strain B7A: Complete Statistical AnalysisIndependent statistical analysis of Human Challenge Model Refinement With Enterotoxigenic Escherichia Coli Strain B7A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02773446).
- Human Factor Validation of Pediatric Mobility Device: Complete Statistical AnalysisIndependent statistical analysis of Human Factor Validation of Pediatric Mobility Device: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03714256).
- Human Factors Study to Validate the User Interface of TOBI Podhaler Using Placebo Capsules: Complete Statistical AnalysisIndependent statistical analysis of Human Factors Study to Validate the User Interface of TOBI Podhaler Using Placebo Capsules: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction: Complete Statistical AnalysisIndependent statistical analysis of Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Human Lung Responses to Respiratory Pathogens: Complete Statistical AnalysisIndependent statistical analysis of Human Lung Responses to Respiratory Pathogens: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01967628).
- Human Papilloma Virus (HPV) Vaccine Immunogenicity and Safety Trial in Young and Adult Women With GSK Biologicals’ HPV-16/18: Complete Statistical AnalysisIndependent statistical analysis of Human Papilloma Virus (HPV) Vaccine Immunogenicity and Safety Trial in Young and Adult Women With GSK Biologicals' HPV-16/18: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection: Complete Statistical AnalysisIndependent statistical analysis of Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00513526).
- Human Participant Study of Prototype Non-medicated Multilayer Foam Dressings on Intact Skin: Complete Statistical AnalysisIndependent statistical analysis of Human Participant Study of Prototype Non-medicated Multilayer Foam Dressings on Intact Skin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Human Perception of Odors and Odor Blockers: Complete Statistical AnalysisIndependent statistical analysis of Human Perception of Odors and Odor Blockers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06191419).
- Human Testing of an Over-the-Counter (OTC) Cream in Children With Eczema: Complete Statistical AnalysisIndependent statistical analysis of Human Testing of an Over-the-Counter (OTC) Cream in Children With Eczema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- HUMBOLDTIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of Filgotinib in Adults With Active Noninfectious Uveitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…